We read with interest the report by Donati et al describing the
presence of human herpesvirus-6 (HHV-6) in a significant proportion of
temporal lobe biopsy samples from patients with intractable mesial
temporal lobe epilepsy. [1] These findings may also be
relevant to patients with late onset transient epileptic amnesia (TEA).
TEA has been defined as episodic transient amnesia (commonly with a
persistent impairment of retrograde or autobiographical memory) in the
absence of other cognitive impairment, with an epileptic basis. [2] The
epileptic activity underlying this syndrome is thought to originate from
the mesial temporal lobes [2,3]. Although treatment with anticonvulsants
may ameliorate the amnesia in some cases, our experience shows that some patients
suffer persistent and occasionally progressive deficits. TEA is a syndrome
generally beginning in later life in patients who have not
had seizures [2]. In many cases, the etiology of the temporal
lobe seizure disorder remains unclear. HHV-6 can (in the context of acute
limbic encephalitis in immunosupressed patients) be associated with
temporal lobe seizures and amnesia [4], may invade the central nervous
system and remain latent [5], and is now demonstrated in patients
with intractable medial temporal lobe epilepsy. [1]
We hypothesize that
TEA might be caused, at least in some cases, by HHV-6 either due to
subacute infection or reactivation. If this hypothesis were confirmed, it
might suggest that early treatment with antiviral agents, in addition to
anticonvulsants, could improve outcome in some of these patients.
References
1. Donati D, Akhyani N, Fogdell-Hahn A et al. Detection of human
herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections.
Neurology. 2003; 61 :1405-11
2. Zeman AZ, Boniface SJ, Hodges JR. Transient epileptic amnesia: a
description of the clinical and neuropsychological features in 10 cases
and a review of the literature. J Neurol Neurosurg Psychiatry. Apr; 64
:435-43.
3. Hogh P, Smith SJ, Scahill RI et al. Epilepsy presenting as AD:
neuroimaging, electroclinical features, and response to treatment.
Neurology. 2002 22; 58 :298-301.
4. Wainwright MS, Martin PL, Morse RP et al. Human herpesvirus 6
limbic encephalitis after stem cell transplantation. Ann Neurol. 2001
;50:612-9.
5. Yoshikawa T, Asano Y. Central nervous system complications in
human herpesvirus-6 infection. Brain and Development 2000; 22: 307-314